Po‐Ming Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 3
- Protein Tyrosine Phosphatases 2
-
- MicroRNA in disease regulation 3
- Co-authors
- Pei‐Yi Chu (15 shared papers)Wei-Chieh Huang (7 shared papers)Shiao-Lin Tung (6 shared papers)Yao‐Li Chen (5 shared papers)Lu‐Hai Wang (3 shared papers)Shuang‐En Chuang (2 shared papers)Yayu Yang (2 shared papers)Sheng‐Chieh Lin (2 shared papers)
- Journals
- International Journal of Molecular Sciences (6 papers)BMC Cancer (3 papers)Cancers (2 papers)Medicine (2 papers)Journal of Biomedical Science (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Po‐Ming Chen
45 papers receiving 745 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 170
- Oncology 185
- Molecular Biology 304
- Orthopedics and Sports Medicine 32
- Immunology and Allergy 22
Countries citing papers authored by Po‐Ming Chen
This map shows the geographic impact of Po‐Ming Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Ming Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Ming Chen more than expected).
Fields of papers citing papers by Po‐Ming Chen
This network shows the impact of papers produced by Po‐Ming Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Ming Chen. The network helps show where Po‐Ming Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Po‐Ming Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 90 | |
| 2 | 2022 | 74 | |
| 3 | 2015 | 51 | |
| 4 | 2018 | 46 | |
| 5 | 2017 | 42 | |
| 6 | 2018 | 41 | |
| 7 | 2014 | 40 | |
| 8 | 2018 | 36 | |
| 9 | Ultrasonography and clinical outcome comparison of extracorporeal shock wave therapy and corticosteroid injections for chronic plantar fasciitis: A randomized controlled trial. | 2018 | 35 |
| 10 | 2020 | 30 | |
| 11 | ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients. | 2016 | 27 |
| 12 | 2017 | 21 | |
| 13 | 2021 | 20 | |
| 14 | 2018 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2022 | 13 | |
| 17 | 2020 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2019 | 12 | |
| 20 | 2020 | 12 |
About Po‐Ming Chen
Po‐Ming Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 45 papers that have together received 747 indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer Cells and Metastasis (3 papers), Cancer Mechanisms and Therapy (3 papers), Epigenetics and DNA Methylation (3 papers), Folate and B Vitamins Research (3 papers), Ferroptosis and cancer prognosis (3 papers), MicroRNA in disease regulation (3 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Cancer Research (170 citations), Oncology (185 citations), Molecular Biology (304 citations), Orthopedics and Sports Medicine (32 citations) and Immunology and Allergy (22 citations). Po‐Ming Chen has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Pei‐Yi Chu, Wei-Chieh Huang, Shiao-Lin Tung, Yao‐Li Chen, Lu‐Hai Wang, Shuang‐En Chuang, Yayu Yang, Sheng‐Chieh Lin, Ping‐Yi Lin and Te‐Hsuan Jang. Their work appears in journals such as International Journal of Molecular Sciences, BMC Cancer, Cancers, Medicine and Journal of Biomedical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.